Novogene Co., Ltd. (SHA:688315)
China
· Delayed Price · Currency is CNY 14.52
+0.12 (0.83%)
Apr 29, 2026, 3:00 PM CST
Novogene Market Cap
Novogene has a market cap or net worth of 5.88 billion as of April 29, 2026. Its market cap has decreased by -5.78% in one year.
Market Cap
5.88B
Enterprise Value
4.35B
Revenue
2.26B
Ranking
n/a
PE Ratio
36.32
Stock Price
14.52
Market Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 5.88B, a decrease of -46.36%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 5.88B | 9.34% |
| Dec 31, 2025 | 5.38B | 6.24% |
| Dec 31, 2024 | 5.06B | -47.88% |
| Dec 29, 2023 | 9.71B | -8.02% |
| Dec 30, 2022 | 10.56B | -36.10% |
| Dec 31, 2021 | 16.53B | 50.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Weiguang Biological Products | 5.88B |
| Lifecome Biochemistry | 5.96B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.98B |
| PharmaResources (Shanghai) | 5.72B |
| Kexing Biopharm | 5.70B |
| Wuhan Hvsen Biotechnology | 5.70B |
| Beijing Konruns Pharmaceutical | 5.69B |
| Innovita Biological Technology | 6.20B |